Go Pro
→ How options let you do more with less capital (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$102.66
0.0%		$90.46
$47.31
▼
$109.57
$4.67B0.54697,620 shs458,308 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$126.07
+0.1%		$114.21
$62.00
▼
$126.79
$4.28B0.62705,922 shs449,895 shs
LivaNova PLC stock logo
LIVN
LivaNova
$78.18
$80.35
$48.82
▼
$85.76
$4.31B0.87535,972 shs552,414 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$22.66
$24.56
$15.59
▼
$35.87
$1.14B1.21802,282 shs838,686 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%-0.33%+12.98%+33.72%+96.54%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%-0.27%+0.58%+38.97%+24.17%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%-4.57%-4.91%-1.91%+39.06%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.00%-3.45%-13.45%-20.13%-18.19%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$102.66
0.0%		$90.46
$47.31
▼
$109.57
$4.67B0.54697,620 shs458,308 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$126.07
+0.1%		$114.21
$62.00
▼
$126.79
$4.28B0.62705,922 shs449,895 shs
LivaNova PLC stock logo
LIVN
LivaNova
$78.18
$80.35
$48.82
▼
$85.76
$4.31B0.87535,972 shs552,414 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$22.66
$24.56
$15.59
▼
$35.87
$1.14B1.21802,282 shs838,686 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%-0.33%+12.98%+33.72%+96.54%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%-0.27%+0.58%+38.97%+24.17%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%-4.57%-4.91%-1.91%+39.06%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.00%-3.45%-13.45%-20.13%-18.19%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Haemonetics Corporation stock logo
HAE
Haemonetics
2.73
Moderate Buy$99.78-2.80% Downside
Integer Holdings Corporation stock logo
ITGR
Integer
2.07
Hold$109.86-12.86% Downside
LivaNova PLC stock logo
LIVN
LivaNova
2.55
Moderate Buy$84.137.60% Upside
STAAR Surgical Company stock logo
STAA
STAAR Surgical
1.92
Reduce$28.4025.33% Upside

Current Analyst Ratings Breakdown

Latest STAA, HAE, LIVN, and ITGR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/3/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$105.00 ➝ $125.00
9/2/2026
LivaNova PLC stock logo
LIVN
LivaNova
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$87.00 ➝ $90.00
9/2/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/21/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$96.00 ➝ $119.00
8/19/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Barrington Research logo
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$95.00 ➝ $118.00
8/19/2026
LivaNova PLC stock logo
LIVN
LivaNova
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/18/2026
LivaNova PLC stock logo
LIVN
LivaNova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
8/18/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$96.00 ➝ $110.00
8/17/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$28.00
8/17/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetHold$31.00 ➝ $28.00
8/13/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$28.00
(Data available from 9/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.33B3.50$7.58 per share13.55$17.14 per share5.99
Integer Holdings Corporation stock logo
ITGR
Integer
$1.85B2.31$10.38 per share12.15$49.85 per share2.53
LivaNova PLC stock logo
LIVN
LivaNova
$1.39B3.10$4.83 per share16.17$21.98 per share3.56
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$239.44M4.75N/AN/A$6.92 per share3.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Haemonetics Corporation stock logo
HAE
Haemonetics
$97.31M$2.0450.3217.922.067.12%27.55%9.65%11/5/2026 (Estimated)
Integer Holdings Corporation stock logo
ITGR
Integer
$102.81M$3.6634.4418.792.406.97%12.79%6.48%10/22/2026 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$3.3823.1318.88N/A12.82%16.35%7.76%11/4/2026 (Estimated)
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-$80.45M$0.07323.7641.96N/A1.13%9.05%6.99%11/4/2026 (Estimated)

Latest STAA, HAE, LIVN, and ITGR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$0.2214$0.39+$0.1686$0.16$90.60 million$93.54 million
8/6/2026Q1 2027
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.08$1.14+$0.06$0.72$327.86 million$339.38 million
8/6/2026Q2 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.09$1.26+$0.17$1.93$380.50 million$390.59 million
8/3/2026Q2 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.38$1.60+$0.22$0.69$451.07 million$464.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Haemonetics Corporation stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Haemonetics Corporation stock logo
HAE
Haemonetics
1.40
3.08
1.91
Integer Holdings Corporation stock logo
ITGR
Integer
0.75
3.73
2.41
LivaNova PLC stock logo
LIVN
LivaNova
0.22
1.45
1.21
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/A
4.66
4.03

Institutional Ownership

CompanyInstitutional Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
99.67%
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
2.07%
Integer Holdings Corporation stock logo
ITGR
Integer
1.10%
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
39.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Haemonetics Corporation stock logo
HAE
Haemonetics
3,00945.50 million44.56 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00033.99 million33.62 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30055.09 million54.90 millionOptionable
STAAR Surgical Company stock logo
STAA
STAAR Surgical
95750.14 million30.14 millionOptionable

Recent News About These Companies

STAAR Surgical (STAA) Swings To Profit On China Rebound
 |  insidermonkey.comhttps://www.insidermonkey.com/blog/staar-surgical-staa-swings-to-profit-on-china-rebound-1837179/
Squarepoint Ops LLC Reduces Position in STAAR Surgical Company $STAA
September 12 at 5:03 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-squarepoint-ops-llc-reduces-position-in-staar-surgical-company-staa-2026-09-12/
STAAR Surgical hires former CEO to lead commercial team
September 11 at 8:21 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/staar-surgical-hires-former-ceo-152900864.html
STAAR Surgical (NASDAQ:STAA) Stock Price Down 5.2% - Here's What Happened
September 11 at 2:59 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-staar-surgical-nasdaq-staa-stock-price-down-52-heres-what-happened-2026-09-11/
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
September 10, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/staar-surgical-releases-landmark-global-110000928.html
Staar Surgical Reappoints David Bailey to Drive Growth
September 10, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/staar-surgical-reappoints-david-bailey-to-drive-growth?utm_source=marketbeat.com&utm_medium=referral
STAAR Surgical Rehires Former CEO David Bailey as Chief Commercial Officer
September 10, 2026  |  visionmonday.comV
STAAR Surgical Appoints David Bailey as Chief Commercial Officer
September 8, 2026  |  marketscreener.comM
Staar Surgical Brings Back Former CEO Bailey as Commercial Chief
September 8, 2026  |  marketwatch.comhttps://www.marketwatch.com/story/staar-surgical-brings-back-former-ceo-bailey-as-commercial-chief-7128990b
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
September 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/staar-surgical-names-former-ceo-200100063.html
Zacks Research Downgrades STAAR Surgical (NASDAQ:STAA) to Hold
September 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-zacks-research-downgrades-staar-surgical-nasdaq-staa-to-hold-2026-09-04/
Bank of New York Mellon Corp Invests $6.58 Million in STAAR Surgical Company $STAA
September 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-invests-658-million-in-staar-surgical-company-staa-2026-09-04/
STAAR Surgical Appoints Ben Park as Chief Technology Officer
September 2, 2026  |  marketscreener.comM
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer
September 2, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/staar-surgical-names-medtech-innovator-200100168.html
STAAR Surgical (NASDAQ:STAA) Trading Up 5.4% - Here's What Happened
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-staar-surgical-nasdaq-staa-trading-up-54-heres-what-happened-2026-09-01/
STAAR Surgical Company (NASDAQ:STAA) Receives Consensus Rating of "Hold" from Brokerages
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-staar-surgical-company-nasdaq-staa-receives-consensus-rating-of-hold-from-brokerages-2026-08-29/
Staar Surgical Targets Presbyopia Growth With New Trifocal ICL Trial
August 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/staar-surgical-targets-presbyopia-growth-with-new-trifocal-icl-trial?utm_source=marketbeat.com&utm_medium=referral
Staar Surgical Advances Next‑Gen ICL Study, Signaling Long‑Term Growth Potential
August 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/staar-surgical-advances-nextgen-icl-study-signaling-longterm-growth-potential?utm_source=marketbeat.com&utm_medium=referral
American Capital Management Inc. Makes New $24.29 Million Investment in STAAR Surgical Company $STAA
August 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-american-capital-management-inc-makes-new-2429-million-investment-in-staar-surgical-company-staa-2026-08-27/
5 insightful analyst questions from STAAR Surgical’s Q2 earnings call
August 20, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/5-insightful-analyst-questions-from-staar-surgical-s-q2-earnings-call/ar-AA2asi4b
Why STAAR Surgical (STAA) shares are sliding today
August 17, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/why-staar-surgical-staa-shares-are-sliding-today/ar-AA2ajyu1

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A quantum computing processor glows inside a gold-plated dilution refrigerator in a research laboratory.
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
By Nathan Reiff | August 17, 2026
NVIDIA logo over a computer chip, server racks, and an upward-trending green stock price chart.
NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
By Thomas Hughes | August 27, 2026
Illustration of a computer chip on a circuit board with an upward green stock chart line in a server room.
Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
By Thomas Hughes | August 31, 2026
Palantir logo displayed on a metallic circular emblem surrounded by digital light streaks and particle effects.
Michael Burry Is Betting Against Palantir Again—Should Investors Care?
By Chris Markoch | August 18, 2026
Palantir logo illuminated in a dark control room with data monitors and a U.S. Capitol building visible in the background.
Cathie Wood Trimmed Palantir, But the Bigger Story Is Still Valuation
By Sam Quirke | September 9, 2026
Haemonetics stock logo

Haemonetics NYSE:HAE

$102.66 -0.04 (-0.03%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$102.25 -0.40 (-0.39%)
As of 04:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Integer stock logo

Integer NYSE:ITGR

$126.06 +0.07 (+0.05%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$125.96 -0.10 (-0.08%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$78.18 0.00 (0.00%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$78.25 +0.07 (+0.09%)
As of 04:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

STAAR Surgical stock logo

STAAR Surgical NASDAQ:STAA

$22.66 0.00 (0.00%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$22.66 0.00 (-0.02%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas